Methodological issues in the assessment of antimalarial drug treatment: Analysis of 13 studies in eight African countries from 2001 to 2004

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3734-3739

  Guthmann, Jean Paul ^a   Pinoges, Loretxu ^a   Checchi, Francesco ^a,b   Cousens, Simon ^b   Balkan, Suna ^c   Van Herp, Michel ^d   Legros, Dominique ^a,e   Olliaro, Piero ^e,f  

^a EPICENTRE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d MÉDECINS SANS FRONTIÈRES   (Belgium)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

AFRICA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG TREATMENT FAILURE; EVALUATION; FEMALE; FOLLOW UP; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

AFRICA; AMODIAQUINE; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; CLINICAL TRIALS; DRUG COMBINATIONS; FEMALE; GENOTYPE; HUMANS; INFANT; MALARIA; MALE; PYRIMETHAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; SULFADOXINE; TREATMENT OUTCOME;

EID: 33750602741     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01618-05     Document Type: Article

References (21)

1. Bachy, C., F. Checchi, and P. Cavailler. 2003. Chloroquine and sulphadoxine-pyrimethamine drug sensitivity study for the treatment of uncomplicated malaria due to Plasmodium falciparum in Mapel, Sudan. Epicentre/MSF, Paris, France.
2. Basco, L. K., and P. Ringwald. 2000. Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 63:215-221.
3. Bonnet, M. 2004. Efficacité de la sulfadoxine- pyriméthamine, amodiaquine, artesunate plus sulfadoxine- pyriméthamine et artesunate plus amodiaquine pour le traitement du paludisme non-compliqué à Plasmodium falciparum, dans le Centre de Santé de Boende, République Démocratique du Congo. Epicentre/MSF Report, Paris, France.
4. Checchi, F., S. Balkan, B. T. Vonhm, M. Massaquoi, P. Biberson, P. Eldin de Pecoulas, P. Brasseur, and J.-P. Guthmann. 2002. Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. Trans. R. Soc. Trop. Med. Hyg. 96:670-673.
5. Checchi, F., P. Piola, C. Kosack, E. Ardizzoni, D. Klarkowski, E. Kwezi, G. Priotto, S. Balkan, N. Bakyaita, A. Brockman, and J.-P. Guthmann. 2004. Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop. Med. Int. Health 9:445-450.
6. Checchi, F., P. Roddy, S. Kamara, A. Williams, G. Morineau, A. R. Wurie, B. Hora, N. Lamotte, T. Baerwaldt, A. Heinzelmann, A. Danks, L. Pinoges, A. Oloo, R. Durand, L. Ranford-Cartwright, and M. de Smet. 2005. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop. Med. Int. Health 10:146-153.
7. de Radiguès, X., K. I. Diallo, P. A. Ngwakun, A. Djimdé, O. Doumbo, M. Diallo, M. van Herp, and J.-P. Guthmann. Submitted for publication.
8. Grandesso, F., C. Bachy, I. Donam, J. Ntambi, J. Habimana, U. d'Alessandro, J. Maikere, V. Vanlerberghe, C. Hinzoumbe Kerah, and J.-P. Guthmann. Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Bongor and Koumra, Chad. Trans. R. Soc. Trop. Med. Hyg., in press.
9. Greenwood, B. M., K. Bojang, C. J. Whitty, and G. A. Targett. 2005. Malaria. Lancet 365:1487-1498.
10. Guthmann, J.-P., J. Ampuero, F. Fortes, C. van Overmeir, V. Gaboulaud, S. Tobback, J. Dunand, N. Saraiva, P. Gillet, J. Franco, A. Denoncin, M. van Herp, S. Balkan, J.-C. Dujardin, U. D'Alessandro, and D. Legros. 2005. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bié provinces, central Angola. Trans. R. Soc. Trop. Med. Hyg. 99:485-492.
11. Irion, A., I. Felger, S. Abdulla, T. Smith, R. Mull, M. Tanner, C. Hatz, and H. P. Beck. 1998. Distinction of recrudescences from new infection by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. Trop. Med. Int. Health 3:490-497.
12. Ranford-Cartwright, L. C., J. Taylor, T. Umasunthar, L. H. Taylor, H. A. Babiker, B. Lell, J. R. Schmidt-Ott, L. G. Lehman, D. Walliker, and P. G. Kremsner. 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:719-724.
13. Snounou, G. 2002. Genotyping of Plasmodium spp. Nested PCR. Methods Mol. Med. 72:103-116.
14. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
15. Stepniewska, K., W. R. Taylor, M. Mayxay, R. Price, F. Smithuis, J.-P. Guthmann, K. Barnes, H. Y. Myint, M. Adjuik, P. Olliaro, S. Pukrittayakamee, S. Looareesuwan, T. T. Hien, J. Farrar, F. Nosten, N. P. Day, and N. J. White. 2004. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob. Agents Chemother. 48:4271-4280.
16. Talisuna, A. O., P. Bloland, and U. D'Alessandro. 2004. History, dynamics, and public health importance of malaria parasite resistance. Clin. Microbiol. Rev. 17:235-254.
17. WHO. 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group. WHO Tech. Rep. Ser. 529:1-21.
18. WHO. 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Document WHO/MAL/96.1077. World Health Organization, Geneva, Switzerland.
19. WHO. 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Document WHO/HTM/RBM/2003.50. World Health Organization, Geneva, Switzerland.
20. WHO. 2006. Guidelines for the treatment of malaria. Document WHO/HTM/MAL/2006.1108. World Health Organization, Geneva, Switzerland. [Online.] http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf.
21. Yeung, S., W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White. 2004. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 71(Suppl. 2):179-186.